These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 19459007)

  • 1. Activity of the antimicrobial peptide and thanatin analog S-thanatin on clinical isolates of Klebsiella pneumoniae resistant to conventional antibiotics with different structures.
    Wu GQ; Ding JX; Li LX; Wang HL; Zhao R; Shen ZL
    Curr Microbiol; 2009 Aug; 59(2):147-53. PubMed ID: 19459007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of S-thanatin, an antimicrobial peptide derived from thanatin, in mouse model of Klebsiella pneumoniae infection.
    Wu G; Wu P; Xue X; Yan X; Liu S; Zhang C; Shen Z; Xi T
    Peptides; 2013 Jul; 45():73-7. PubMed ID: 23643614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The activity of antimicrobial peptide S-thanatin is independent on multidrug-resistant spectrum of bacteria.
    Wu G; Li X; Fan X; Wu H; Wang S; Shen Z; Xi T
    Peptides; 2011 Jun; 32(6):1139-45. PubMed ID: 21453736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thanatin activity on multidrug resistant clinical isolates of Enterobacter aerogenes and Klebsiella pneumoniae.
    Pagès JM; Dimarcq JL; Quenin S; Hetru C
    Int J Antimicrob Agents; 2003 Sep; 22(3):265-9. PubMed ID: 13678832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial polymers as therapeutics for treatment of multidrug-resistant Klebsiella pneumoniae lung infection.
    Lou W; Venkataraman S; Zhong G; Ding B; Tan JPK; Xu L; Fan W; Yang YY
    Acta Biomater; 2018 Sep; 78():78-88. PubMed ID: 30031912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of
    Zhang W; Guo Y; Yang Y; Dong D; Zheng Y; Zhu D; Hu F
    Microb Drug Resist; 2020 Mar; 26(3):204-210. PubMed ID: 31553260
    [No Abstract]   [Full Text] [Related]  

  • 7. Antimicrobial activity of two novel antimicrobial peptides AA139 and SET-M33 against clinically and genotypically diverse Klebsiella pneumoniae isolates with differing antibiotic resistance profiles.
    van der Weide H; Vermeulen-de Jongh DMC; van der Meijden A; Boers SA; Kreft D; Ten Kate MT; Falciani C; Pini A; Strandh M; Bakker-Woudenberg IAJM; Hays JP; Goessens WHF
    Int J Antimicrob Agents; 2019 Aug; 54(2):159-166. PubMed ID: 31173867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of cations and pH on antimicrobial activity of thanatin and s-thanatin against Escherichia coli ATCC25922 and B. subtilis ATCC 21332.
    Wu G; Ding J; Li H; Li L; Zhao R; Shen Z; Fan X; Xi T
    Curr Microbiol; 2008 Dec; 57(6):552-7. PubMed ID: 18810542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic activity of synthetic N-terminal peptide of human lactoferrin in combination with various antibiotics against carbapenem-resistant Klebsiella pneumoniae strains.
    Morici P; Florio W; Rizzato C; Ghelardi E; Tavanti A; Rossolini GM; Lupetti A
    Eur J Clin Microbiol Infect Dis; 2017 Oct; 36(10):1739-1748. PubMed ID: 28470337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymyxin B in combination with meropenem against carbapenemase-producing Klebsiella pneumoniae: pharmacodynamics and morphological changes.
    Sharma R; Patel S; Abboud C; Diep J; Ly NS; Pogue JM; Kaye KS; Li J; Rao GG
    Int J Antimicrob Agents; 2017 Feb; 49(2):224-232. PubMed ID: 28040408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TPGS-based and S-thanatin functionalized nanorods for overcoming drug resistance in Klebsiella pneumonia.
    Wang X; Xu X; Zhang S; Chen N; Sun Y; Ma K; Hong D; Li L; Du Y; Lu X; Jiang S
    Nat Commun; 2022 Jun; 13(1):3731. PubMed ID: 35768446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalent phenotypes and antibiotic resistance in Escherichia coli and Klebsiella pneumoniae at an Indian tertiary care hospital: plasmid-mediated cefoxitin resistance.
    Shahid M; Malik A; Akram M; Agrawal LM; Khan AU; Agrawal M
    Int J Infect Dis; 2008 May; 12(3):256-64. PubMed ID: 17981482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo bactericidal activity of ceftazidime-avibactam against Carbapenemase-producing
    Zhang W; Guo Y; Li J; Zhang Y; Yang Y; Dong D; Zhu D; He P; Hu F
    Antimicrob Resist Infect Control; 2018; 7():142. PubMed ID: 30479755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic antibiotic combinations for colistin-resistant Klebsiella pneumoniae.
    Kádár B; Kocsis B; Tóth Á; Damjanova I; Szász M; Kristóf K; Nagy K; Szabó D
    Acta Microbiol Immunol Hung; 2013 Jun; 60(2):201-9. PubMed ID: 23827751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antimicrobial peptide thanatin disrupts the bacterial outer membrane and inactivates the NDM-1 metallo-β-lactamase.
    Ma B; Fang C; Lu L; Wang M; Xue X; Zhou Y; Li M; Hu Y; Luo X; Hou Z
    Nat Commun; 2019 Aug; 10(1):3517. PubMed ID: 31388008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of minocycline combined with aminoglycosides against Klebsiella pneumoniae carbapenemase-producing K. pneumoniae.
    Wentao N; Guobao L; Jin Z; Junchang C; Rui W; Zhancheng G; Youning L
    J Antibiot (Tokyo); 2018 May; 71(5):506-513. PubMed ID: 29416121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro pharmacodynamics of colistin against multidrug-resistant Klebsiella pneumoniae.
    Poudyal A; Howden BP; Bell JM; Gao W; Owen RJ; Turnidge JD; Nation RL; Li J
    J Antimicrob Chemother; 2008 Dec; 62(6):1311-8. PubMed ID: 18922815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic effect and antibiofilm activity of the antimicrobial peptide K11 with conventional antibiotics against multidrug-resistant and extensively drug-resistant
    Chatupheeraphat C; Peamchai J; Luk-In S; Eiamphungporn W
    Front Cell Infect Microbiol; 2023; 13():1153868. PubMed ID: 37113135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of the antibacterial activity of a short cationic peptide against multidrug-resistant Klebsiella pneumoniae and Salmonella typhimurium strains and its cytotoxicity on eukaryotic cells.
    Moghaddam MM; Barjini KA; Ramandi MF; Amani J
    World J Microbiol Biotechnol; 2014 May; 30(5):1533-40. PubMed ID: 24323118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Underlying mechanism of in vivo and in vitro activity of C-terminal-amidated thanatin against clinical isolates of extended-spectrum beta-lactamase-producing Escherichia coli.
    Hou Z; Lu J; Fang C; Zhou Y; Bai H; Zhang X; Xue X; Chen Y; Luo X
    J Infect Dis; 2011 Jan; 203(2):273-82. PubMed ID: 21288828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.